Analysis A: 10-day equivalent periods |
Case, No. | 253a | 173a |
Exposed | 24 | 17 |
Unexposed | 229 | 156 |
Control, No. | 949 | 647 |
Exposed | 124 | 89 |
Unexposed | 825 | 558 |
Overall, OR (95% CI) | 0.64 (0.39–1.00)b | 0.63 (0.34–1.08) |
Sex, OR (95% CI) | | |
Male | 0.64 (0.31–1.32) | 0.82 (0.36–1.86) |
Female | 0.64 (0.34–1.05) | 0.52 (0.25–1.07) |
Age-group, OR (95% CI) | | |
1–11 y | 0.50 (0.11–2.27) | 0.40 (0.04–3.69) |
12–18 y | 0.66 (0.41–1.04) | 0.65 (0.37–1.12) |
Mental health history, OR (95% CI) | | |
No | 0.62 (0.35–1.08) | 0.51 (0.26–1.00) |
Yes | 0.68 (0.33–1.42) | 0.99 (0.39–2.45) |
History of suicide attempt, OR (95% CI) | | |
No | 0.62 (0.39–0.99) | 0.30 (0.04–2.38) |
Yes | 0.91 (0.18–4.53) | 0.67 (0.39–1.18) |
Influenza vaccine during season, OR (95% CI) | | |
No | 0.71 (0.45–1.13) | 0.60 (0.33–1.07) |
Yes | 0.19 (0.03–1.46) | 0.84 (0.22–3.19) |
Analysis B: 5-day case period, 10-day washout, 5-day control period | | |
Case, No. | 253 | 173 |
Exposed | 16 | 10 |
Unexposed | 237 | 163 |
Control, No. | 985 | 673 |
Exposed | 74 | 74 |
Unexposed | 911 | 599 |
Overall association, OR (95% CI) | 0.82 (0.45–1.43) | 0.48 (0.22–0.95)c |
Analysis C: 15-day equivalent periods | | |
Case, No. | 253 | 173 |
Exposed | 28 | 24 |
Unexposed | 225 | 149 |
Control, No. | 886 | 595 |
Exposed | 150 | 96 |
Unexposed | 736 | 499 |
Overall association, OR (95% CI) | 0.57 (0.36–0.86)d | 0.72 (0.43–1.15) |